Rho kinase inhibitors—a review on the physiology and clinical use in Ophthalmology

Nuno Moura-Coelho, Joana Tavares Ferreira, Carolina Pereira Bruxelas, Marco Dutra-Medeiros, João Paulo Cunha, Rita Pinto Proença

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

The Rho kinase (ROCK) signaling pathway is involved in several cellular events that include cell proliferation and cytoskeleton modulation leading to cell adhesion. The ROCK pathway in the human eye has been hypothesized to play important roles in corneal endothelial cell physiology and pathologic states. In addition, ROCK signaling has been identified as an important regulator of trabecular meshwork (TM) outflow, which is altered in glaucomatous eyes. These roles in corneal and glaucomatous disease states have led to the growing interest in the development of drugs selectively targeting this pathway (ROCK inhibitors). The authors provide a review of the literature on the pathobiology of the ROCK signaling in corneal endothelial disease, glaucoma, and vitreoretinal disease, as well as the clinical usefulness of ROCK inhibitors in Ophthalmology.

Original languageEnglish
Pages (from-to)1101-1117
JournalGraefe's Archive for Clinical and Experimental Ophthalmology
Volume257
Issue number6
DOIs
Publication statusPublished - Mar 2019

Fingerprint

Corneal Diseases
rho-Associated Kinases
Ophthalmology
Trabecular Meshwork
Cell Physiological Phenomena
Drug Delivery Systems
Cytoskeleton
Cell Adhesion
Glaucoma
Endothelial Cells
Cell Proliferation

Keywords

  • Corneal endothelial disease
  • Glaucoma
  • Rho kinase
  • Rho kinase inhibitors
  • Vitreoretinal disease

Cite this

@article{5ccfa1d098fe43dfa7ff83fd6e2058f2,
title = "Rho kinase inhibitors—a review on the physiology and clinical use in Ophthalmology",
abstract = "The Rho kinase (ROCK) signaling pathway is involved in several cellular events that include cell proliferation and cytoskeleton modulation leading to cell adhesion. The ROCK pathway in the human eye has been hypothesized to play important roles in corneal endothelial cell physiology and pathologic states. In addition, ROCK signaling has been identified as an important regulator of trabecular meshwork (TM) outflow, which is altered in glaucomatous eyes. These roles in corneal and glaucomatous disease states have led to the growing interest in the development of drugs selectively targeting this pathway (ROCK inhibitors). The authors provide a review of the literature on the pathobiology of the ROCK signaling in corneal endothelial disease, glaucoma, and vitreoretinal disease, as well as the clinical usefulness of ROCK inhibitors in Ophthalmology.",
keywords = "Corneal endothelial disease, Glaucoma, Rho kinase, Rho kinase inhibitors, Vitreoretinal disease",
author = "Nuno Moura-Coelho and {Tavares Ferreira}, Joana and Bruxelas, {Carolina Pereira} and Marco Dutra-Medeiros and Cunha, {Jo{\~a}o Paulo} and {Pinto Proen{\cc}a}, Rita",
year = "2019",
month = "3",
doi = "10.1007/s00417-019-04283-5",
language = "English",
volume = "257",
pages = "1101--1117",
journal = "Graefe's Archive for Clinical and Experimental Ophthalmology",
issn = "0721-832X",
publisher = "Springer Verlag",
number = "6",

}

Rho kinase inhibitors—a review on the physiology and clinical use in Ophthalmology. / Moura-Coelho, Nuno; Tavares Ferreira, Joana; Bruxelas, Carolina Pereira; Dutra-Medeiros, Marco; Cunha, João Paulo; Pinto Proença, Rita.

In: Graefe's Archive for Clinical and Experimental Ophthalmology, Vol. 257, No. 6, 03.2019, p. 1101-1117.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Rho kinase inhibitors—a review on the physiology and clinical use in Ophthalmology

AU - Moura-Coelho, Nuno

AU - Tavares Ferreira, Joana

AU - Bruxelas, Carolina Pereira

AU - Dutra-Medeiros, Marco

AU - Cunha, João Paulo

AU - Pinto Proença, Rita

PY - 2019/3

Y1 - 2019/3

N2 - The Rho kinase (ROCK) signaling pathway is involved in several cellular events that include cell proliferation and cytoskeleton modulation leading to cell adhesion. The ROCK pathway in the human eye has been hypothesized to play important roles in corneal endothelial cell physiology and pathologic states. In addition, ROCK signaling has been identified as an important regulator of trabecular meshwork (TM) outflow, which is altered in glaucomatous eyes. These roles in corneal and glaucomatous disease states have led to the growing interest in the development of drugs selectively targeting this pathway (ROCK inhibitors). The authors provide a review of the literature on the pathobiology of the ROCK signaling in corneal endothelial disease, glaucoma, and vitreoretinal disease, as well as the clinical usefulness of ROCK inhibitors in Ophthalmology.

AB - The Rho kinase (ROCK) signaling pathway is involved in several cellular events that include cell proliferation and cytoskeleton modulation leading to cell adhesion. The ROCK pathway in the human eye has been hypothesized to play important roles in corneal endothelial cell physiology and pathologic states. In addition, ROCK signaling has been identified as an important regulator of trabecular meshwork (TM) outflow, which is altered in glaucomatous eyes. These roles in corneal and glaucomatous disease states have led to the growing interest in the development of drugs selectively targeting this pathway (ROCK inhibitors). The authors provide a review of the literature on the pathobiology of the ROCK signaling in corneal endothelial disease, glaucoma, and vitreoretinal disease, as well as the clinical usefulness of ROCK inhibitors in Ophthalmology.

KW - Corneal endothelial disease

KW - Glaucoma

KW - Rho kinase

KW - Rho kinase inhibitors

KW - Vitreoretinal disease

UR - http://www.scopus.com/inward/record.url?scp=85062688043&partnerID=8YFLogxK

U2 - 10.1007/s00417-019-04283-5

DO - 10.1007/s00417-019-04283-5

M3 - Review article

VL - 257

SP - 1101

EP - 1117

JO - Graefe's Archive for Clinical and Experimental Ophthalmology

JF - Graefe's Archive for Clinical and Experimental Ophthalmology

SN - 0721-832X

IS - 6

ER -